Companies
AstraZeneca
PharmaceuticalsCambridge, United KingdomAZN95,100 employees
More about AstraZeneca
Drugmaker that develops and sells prescription medicines in oncology, cardiovascular, renal, respiratory and rare diseases
Revenue
$58.7B
Fiscal 2025, up about 9%
Employees
95,100
As of December 2025
Stock
AZN
New York Stock Exchange
Headquarters
Cambridge, United Kingdom
CEO
Pascal Soriot
Since October 2012
BrandsTagrisso, Farxiga, Imfinzi, Enhertu, Alexion
Current strategyAiming for $80B in annual revenue and 20 new medicines by 2030; listed its ordinary shares directly on the NYSE in February 2026
CompetitorsPfizer, Novartis, Roche
Checked October 11, 2026 · Sources: sec.gov, astrazeneca.com
Be the first to post about AstraZeneca
No one has started a discussion here yet. Yours is anonymous and appears right away, and we don’t store who wrote it.
Or follow AstraZeneca to see the first post in your watchlist.
Follow AstraZeneca in a feed reader, no account needed: RSS feed